News & Updates
Filter by Specialty:
Ovarian reserve damage less with ablation vs cystectomy for endometrioma
In the treatment of patients with endometrioma, both ablation and cystectomy cause significant damage to ovarian reserve, although the extent of damage appears to be less with ablation, as shown in a study.
Ovarian reserve damage less with ablation vs cystectomy for endometrioma
07 Nov 2022Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
For pregnant women with HIV who are receiving dolutegravir (DTG)-based therapies, the two-drug regimen works just as well as three-drug regimens at keeping the viral load to "undetectable" levels without exerting serious adverse effects on neonatal outcomes, according to a study presented at HIV Glasgow 2022 Congress.
Two-drug dolutegravir-based regimen a valid alternative for pregnant women with HIV
07 Nov 2022Extended-release nifedipine benefits women with severe pre-eclampsia
Treatment with extended-release nifedipine helps reduce intrapartum acute hypertensive therapy among pre-eclampsia patients with severe features, as reported in a study.
Extended-release nifedipine benefits women with severe pre-eclampsia
02 Nov 2022TNF inhibition beyond 24 weeks: How safe in pregnant mums?
Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.
TNF inhibition beyond 24 weeks: How safe in pregnant mums?
02 Nov 2022Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.
Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
01 Nov 2022Oral GnRH antagonists effective in endometriosis-related pain, dysmenorrhea
Oral gonadotropin-releasing hormone (GnRH) antagonists help relieve pain in women with endometriosis or dysmenorrhea, according to the results of a meta-analysis.